Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.

Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.

Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.&nbsp;

Microdosing GLP-1 and Cagrisema headlines

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Share Microdosing GLP-1 and Cagrisema headlines

Sign up to save your podcasts

Microdosing GLP-1 and Cagrisema headlines

Microdosing GLP-1 and Cagrisema headlines

More shows like Docs Who Lift

The Jordan Syatt Podcast

Everyday Wellness with Cynthia Thurlow ™

The Hormone Solution with Karen Martel

The Holistic GLP-1 Podcast with Elizabeth McGann

The Hunter Williams Podcast

The Thyroid Fixer

The Dr. Tyna Show

The Dr. Gabrielle Lyon Show

The Peptide Podcast

The Obesity Guide with Matthea Rentea MD

The Plus SideZ: A Guide to GLP-1 & Metabolic Health

Fat Science

On The Pen With Dave Knapp

GLP-1 Hub: Support, Community, and Weight Loss